ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought

July 27, 1984

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010